MoonLake Immunotherapeutics

MLTX

Equity

ISIN KY61559X1045 / Valor 118139749

NASDAQ (2026-03-27)

USD 17.32-2.42%

MoonLake Immunotherapeutics
UMushroom community rating:

4.25 2 votes No rating yet

NegativeNeutralPositive

About company

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company focused on developing innovative treatments for inflammatory diseases. The company's primary asset is Sonelokimab, an investigational Nanobody® designed to target and treat inflammation more effectively. By leveraging advanced biotechnological approaches, MoonLake aims to improve patient outcomes in conditions characterized by chronic inflammation. The company is dedicated to advancing Sonelokimab through clinical trials to establish its efficacy and safety, positioning itself as a key player in the biopharmaceutical industry’s efforts to address unmet medical needs in inflammatory diseases.

Summarized from source with an LLMView SourceSector: Finance

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-56.5%1Y

-25.2%3Y

%5Y

Performance

242%1Y

155%3Y

147%5Y

Volatility

1242 M

Market cap (USD)

479,019

Daily traded volume (Shares)

55.19 / 52.6

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.25

2 votes

Performance:

4.38

Innovation:

4.00

Society:

4.25

Nature:

4.25

Alex Roberts

United Kingdom, 17 Dec 2025

Should've listened to this guy -->

Alex Roberts

United Kingdom, 20 Nov 2025

up 40% since I added a month ago, bounce back after potential lawsuit. Potential takeover looming

EQUITIES OF THE SAME SECTOR

Investor AB

Investor AB Valor: 111465893

Annual Return

-50%0%+50%

Risk level

110

-0.17%SEK 342.90

Swedbank AB

Swedbank AB Valor: 212308

Annual Return

-50%0%+50%

Risk level

110

1.22%SEK 307.90

OEKOWORLD AG

OEKOWORLD AG Valor: 1472233

Annual Return

-50%0%+50%

Risk level

110

-1.90%EUR 25.80

Protector Forsikring Asa

Protector Forsikring Asa Valor: 2213231

Annual Return

-50%0%+50%

Risk level

110

-0.97%NOK 459.00

Avance Gas Holding Ltd

Avance Gas Holding Ltd Valor: 22521814

Annual Return

-50%0%+50%

Risk level

110

77.78%NOK 0.24

Credicorp Ltd

Credicorp Ltd Valor: 12931

Annual Return

-50%0%+50%

Risk level

110

-1.86%USD 322.43

Federal Realty Investment Trust

Federal Realty Investment Trust Valor: 115648878

Annual Return

-50%0%+50%

Risk level

110

-0.80%USD 102.87

Hilltop Holdings Inc.

Hilltop Holdings Inc. Valor: 3296744

Annual Return

-50%0%+50%

Risk level

110

-1.21%USD 35.20

Clariane

Clariane Valor: 2743781

Annual Return

-50%0%+50%

Risk level

110

0.24%EUR 3.41

Herc Holdings Inc

Herc Holdings Inc Valor: 32837395

Annual Return

-50%0%+50%

Risk level

110

-4.28%USD 100.34

Logos provided by Clearbit

MoonLake Immunotherapeutics

MLTX

ISIN KY61559X1045 / Valor 118139749

MoonLake Immunotherapeutics UMushroom community rating:

Alex Roberts

Alex Roberts

MoonLake Immunotherapeutics
UMushroom community rating: